CIK 0001840229 · <br>Emerging growth company
MiNK Therapeutics, Inc.
Sign in to watch- Ticker
- INKT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 212-994-8250
- Business address
- 149 FIFTH AVENUE, SUITE 500, NEW YORK, NY, 10010
- Former names
- AgenTus Therapeutics, Inc., AgenTus Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $73,265
- in 1 filing
Net −$73,265. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 30 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-01 | Behner Peter Director | Grant or award | +10,531 | $1.46 | $15K | 44,058 |
| 2023-09-01 | Corvese Brian Director | Grant or award | +12,244 | $1.46 | $18K | 329,523 |
| 2023-09-01 | Baldoni John Director | Grant or award | +9,846 | $1.46 | $14K | 41,193 |
| 2023-09-01 | Ryan Barbara Director | Grant or award | +12,158 | $1.46 | $18K | 50,864 |
| 2023-09-01 | WIINBERG ULF Director | Grant or award | +9,590 | $1.46 | $14K | 60,119 |
| 2023-08-29 | AGENUS INC 10% owner | Purchase | +29,678 | $1.52 | $45K | 21,734,887 |
| 2023-08-28 | AGENUS INC 10% owner | Purchase | +12,808 | $1.45 | $19K | 21,705,209 |
| 2023-08-24 | AGENUS INC 10% owner | Purchase | +170,244 | $1.54 | $263K | 21,692,401 |
| 2023-06-14 | Behner Peter Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-06-14 | Ryan Barbara Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2023-06-14 | Corvese Brian Director | Grant or award · Stock Option (Right to Buy) | +37,500 | 37,500 | ||
| 2023-06-14 | Baldoni John Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-06-14 | WIINBERG ULF Director | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2023-06-01 | Corvese Brian Director | Grant or award | +10,157 | $1.76 | $18K | 317,505 |
| 2023-06-01 | Ryan Barbara Director | Grant or award | +10,086 | $1.76 | $18K | 38,930 |
| 2023-06-01 | Behner Peter Director | Grant or award | +8,736 | $1.76 | $15K | 33,721 |
| 2023-06-01 | WIINBERG ULF Director | Grant or award | +7,955 | $1.76 | $14K | 50,706 |
| 2023-06-01 | Baldoni John Director | Grant or award | +8,168 | $1.76 | $14K | 31,528 |
| 2023-05-11 | AGENUS INC 10% owner | Purchase | +23,361 | $1.43 | $33K | 21,640,473 |
| 2023-05-10 | AGENUS INC 10% owner | Purchase | +22,065 | $1.51 | $33K | 21,617,112 |
Page 6 of 7 · 126 trades